Laura Rogers
Gerontology · Gulfport, MSNPI 1558872929
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 281 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 25.9% of the total. 2025 is the largest year on record at $1,591, 2.5 times the $631 reported in 2021.
Across 281 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$700
- Takeda Pharmaceuticals U.S.A., Inc.$420
- Ardelyx, Inc.$301
- Ironwood Pharmaceuticals, Inc$249
- Intercept Pharmaceuticals, Inc.$210
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,391100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $1,395 |
| Johnson & Johnson(2 entities) | 36 | $700 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $420 |
| Ardelyx, Inc. | 14 | $301 |
| Ironwood Pharmaceuticals, Inc | 14 | $249 |
| Intercept Pharmaceuticals, Inc. | 13 | $210 |
| Regeneron Healthcare Solutions, Inc. | 6 | $179 |
| Gilead | 9 | $166 |
| Ipsen Biopharmaceuticals, Inc | 7 | $158 |
| Phathom Pharmaceuticals, Inc. | 9 | $153 |
| Evoke Pharma, Inc. | 9 | $147 |
| Bristol Myers Squibb | 7 | $141 |
| Nestle Healthcare Nutrition Inc. | 7 | $126 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $125 |
| Lilly USA, LLC | 5 | $89 |
| Celltrion USA Inc. | 4 | $84 |
| Astellas Pharma US Inc | 4 | $80 |
| Actelion Pharmaceuticals US, Inc. | 4 | $76 |
| Aimmune Therapeutics, Inc. | 4 | $65 |
| Pharmacosmos Therapeutics Inc. | 3 | $65 |
| Boehringer Ingelheim | 3 | $56 |
| Viiv Healthcare Company | 3 | $56 |
| Mallinckrodt Hospital Products Inc. | 3 | $55 |
| QOL Medical, LLC | 3 | $54 |
| Pfizer | 3 | $52 |
| Abbott | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Orphalan Inc | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Merck | 1 | $22 |
| Sanofi | 1 | $20 |
| Apria Healthcare LLC | 1 | $16 |
| Amgen | 1 | $14 |
| Braintree Laboratories, Inc. | 1 | $13 |
How this compares
$5,391 in reported general payments places this provider in the 85th percentile of 66 gerontology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 27 | $35,765 |
| Colestipol Hcl | 76 | $10,049 |
| Omeprazole | 435 | $5,064 |
| Pantoprazole Sodium | 225 | $3,322 |
| Famotidine | 242 | $2,496 |
| Dicyclomine Hcl | 57 | $1,534 |
| Esomeprazole Magnesium | 34 | $1,394 |
| Sucralfate | 28 | $1,275 |
| Lansoprazole | 22 | $1,194 |
| Ondansetron Hcl | 51 | $1,162 |
| Glycopyrrolate | 22 | $732 |
| Buspirone Hcl | 58 | $523 |
| Metoclopramide Hcl | 11 | $107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,395 | $35,76527 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 66 gerontology providers in Mississippi.
Other gerontology in Gulfport
- Addie HolcombGulfport$7K
- Tiffany SandersGulfport$2K
- Leigh van DevenderOxford$16K
- Justin ColeLaurel$14K
- Shannon WoodsSouthaven$14K
- Shavonne DoyleOxford$14K
- Meghan MillsTupelo$10K
- Daniel WelchJackson$8K
- Alexandria TannerOcean Springs$5K
- Katlyn AmasonFlowood$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.